| Pharmaceutical active ingredients: |
| Guanidine Glycolate |
| Available forms, composition and doses of Ikeriane: |
| N / A |
| Ikeriane medical category: |
| Human:Guanine oxidation derivatives |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| C02CC - Guanidine derivativesC02DG - Guanidine derivatives |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Pierre Fabre |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Ictyane Crema | Glycerol; Paraffin Soft White | Pierre Fabre; Silesia Laboratorios |
| Iderpes | Idoxuridine | Pierre Fabre |
| Ikaran | Dihydroergotamine Mesylate | Pierre Fabre; Formenti Farmaceutici; Nycomed; Robapharm |
| Ikaran LP | Dihydroergotamine Mesylate | Pierre Fabre |
| Ikaran Retard | Dihydroergotamine Mesylate | Pierre Fabre; Robapharm |
| Immucytal | Haemophilus Influenzae; Klebsiella Pneumoniae Membrane Fraction; Klebsiella Pneumoniae Ribosomal Fraction; Streptococcus Pneumoniae; Streptococcus Pyogenes | Pierre Fabre |
| Immugrip | Influenza Virus Inactivated Fragmented | Pierre Fabre |
| Incital | Mefenorex Hydrochloride | Pierre Fabre |
| Iskedyl | Dihydroergocristine Mesylate; Raubasine | Pierre Fabre |
| Iskedyl Fort | Dihydroergocristine Mesylate; Raubasine | Pierre Fabre |